The Journal of Thoracic and Cardiovascular Surgery, Vol 87, 244-250, Copyright © 1984 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
Management of intracardiac fungal masses in premature infants
JE Foker, JL Bass, T Thompson, JA Tilleli and DE Johnson
Intracardiac fungal masses can develop following episodes of candidemia in
premature infants with indwelling right atrial lines. We report the first
premortem diagnosis and successful surgical removal of Candida- containing
intracardiac masses in three premature infants. All had central venous
lines and had been on systemic antibiotics prior to the development of
candidemia. By echocardiography, two were pedunculated, solitary masses
within the right atrium. Amphotericin B and 5- flucytosine for 21 to 42
days controlled the Candida sepsis, but the masses became increasingly
mobile and did not decrease in size. In the third infant, large, irregular
masses extended from the right atrium to the main pulmonary artery, and
surgical removal was recommended 4 days after the start of antifungal
therapy. In all three patients, the masses were nearly the size of the main
pulmonary artery and presumably contained viable organisms. Removal was
accomplished with the aid of cardiopulmonary bypass for two and inflow
stasis for one infant weighing only 1,300 gm. The masses were filled with
viable Candida organisms. All patients tolerated the operation well and
have been followed up for 1 to 3.6 years without evidence of recurrent
Candida infection. The case of a fourth infant, weighing 1,320 gm, is also
reported. This infant had a bacteria-containing intra-atrial mass, which
was removed successfully with the aid of inflow occlusion. This report
documents the following points: (1) Echocardiography provides a noninvasive
method of diagnosing the development of intracardiac masses and should be
performed in infants who have had candidemia and a central venous line. (2)
Prolonged systemic antifungal therapy does not appear to either sterilize
or promote regression of the masses. (3) The masses can be safely removed,
even in the premature infant, with either inflow stasis or cardiopulmonary
bypass. (4) Surgical removal is an effective component of the treatment of
infection in these infants.